Peer review panels really can suss out good science, and clinical trials could get extremely personal.

Newt Gingrich wants to double spending on medical research, and Chinese researchers highlight the hazards of editing human genomes.

A new method for labeling cell lines and checking their quality could improve the validity of study results.

Trials to test drugs for autism suffer from subjective measurements and placebo effects. Helen Tager-Flusberg outlines how to ferret out the true effects of potential autism therapies.

A panel of genes expressed in blood may identify toddlers who will later be diagnosed with autism.

The National Institute of Mental Health is overhauling its funding strategy to emphasize the translation of advances in genomics and information technology into therapies.

A biotech breakthrough sparks a high-stakes patent war, and two new films follow people with autism looking for love.

Watch the complete replay of Helen Tager-Flusberg’s webinar discussing what language differences in autism reveal about the disorder’s biology.

Apple’s new tool for creating apps to aid medical research may provide autism researchers with easy access to vast numbers of study participants — and data.

A boy with autism maps the world from memory, and would-be profs are trapped in perpetual postdocs.